Richard Colvin
Technik-/Wissenschafts-/F&E-Leiter bei BLUEBIRD BIO, INC.
Vermögen: 108 070 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Richard Colvin
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 55 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Richard Colvin
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ABIOMED, INC. | Medical Specialties | Investor Relations Contact Director of Finance/CFO | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO Comptroller/Controller/Auditor Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| WALMART INC. | Specialty Stores | Corporate Officer/Principal | |
| MAGELLAN HEALTH, INC. | Medical/Nursing Services | Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Public Communications Contact Chief Tech/Sci/R&D Officer Director/Board Member Sales & Marketing | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Proclara Biosciences, Inc.
 Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Doctorate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree | |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Operating Officer | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
| Bentley University | College/University | Graduate Degree Undergraduate Degree | |
| Boston College | College/University | Graduate Degree Undergraduate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree | |
| University of Delaware | College/University | Doctorate Degree | |
| Wesleyan University | College/University | Undergraduate Degree Undergraduate Degree | |
| Georgetown University | College/University | Masters Business Admin Undergraduate Degree | |
| Wheaton College (Massachusetts) | College/University | Undergraduate Degree Undergraduate Degree | |
| US Department of Health & Human Services (DC) | General Government | Corporate Officer/Principal | |
| NOVOCURE LIMITED | Medical Specialties | Investor Relations Contact | |
GV Management Co. LLC
 GV Management Co. LLC Investment ManagersFinance GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
North Texas Commission
 North Texas Commission Miscellaneous Commercial ServicesCommercial Services The North Texas Commission is a public-private partnership that manages the region's unified advocacy voice at the state and federal levels. The private company is based in Irving, TX. The commission is dedicated to advancing the vibrancy of the region and achieves impactful outcomes benefiting the 13-county area it serves. As the lead convener of subject matter experts, the NTC improves the workforce pipeline and cultivates future leaders. The CEO of the company is Chris Wallace. | Miscellaneous Commercial Services | Director/Board Member | |
| Harvard Medical School | College/University | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| The Fuqua School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| University of Maryland Baltimore County | College/University | Undergraduate Degree | |
| 2SEVENTY BIO, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chairman Chief Executive Officer Human Resources Officer Director/Board Member Director/Board Member Investor Relations Contact Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor Private Equity Investor | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Chief Executive Officer Chairman Director/Board Member | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| PRIME MEDICINE, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Biotechnology | Human Resources Officer | |
| New York University School of Medicine | College/University | Doctorate Degree | |
| World Health Organization (United States) | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 46 |
| Vereinigtes Königreich | 3 |
| Schweiz | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 19 |
| Finance | 4 |
| Health Services | 3 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 160 |
| Corporate Officer/Principal | 119 |
| Independent Dir/Board Member | 67 |
| Undergraduate Degree | 44 |
| Chairman | 29 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Daniel Lynch | 32 |
| Wendy Dixon | 25 |
| Mary Lynne Hedley | 25 |
| Mark Vachon | 19 |
| Denice Torres | 19 |
| David Schenkein | 18 |
| John Agwunobi | 15 |
| William R. Sellers | 14 |
| Gina Consylman | 14 |
| Jeffrey Walsh | 14 |
| Joseph Vittiglio | 14 |
| Katherine Edna Breedis | 13 |
| Sarah Glickman | 13 |
| James Mandell | 13 |
| Nick Leschly | 13 |
- Börse
- Insiders
- Richard Colvin
- Unternehmensverbindungen
